FDA accepts the idea of traditional Chinese medicine idea

Straight through a variety of herbs used to give medical treatment. The sauce Aochu If herbal medicine to the treatment of certain diseases, why bother to write this easily the pharmaceutical formula it? It works, it will be enough.

The U.S. Food and Drug Administration (FDA) has the opposite view. The world's most stringent Drug institutions, for decades has been to the approval of the sale of herbal applications turned up their noses. Western pharmacology studies focused on identifying ways to treat diseases of a single compound. Pfizer and Merck, and other pharmaceutical companies often spend billions of dollars, tens of thousands of compounds to verify one by one to find out exactly what kind of treatment is a disease of the Miao-quick fixes.

East and West, the difference can be condensed into a simple question: in medical treatment, as in the West as "a deadly bomb" approach, has a clear effect on heart disease compounds Live's "Gate of Life" , As China is "playing shotgun" approach, full bloom, as long as they can hit on the goal line?

After the FDA on a way to accept less. The agency will measure the standards of other drugs, rigidly applied to the herbal medicine, require developers to identify herbal medicines in is exactly what kind of ingredients to treat and to prove its effectiveness. In the United States, with the use of traditional Chinese medicine ginkgo and Echinacea purpurea, and other plant-based medicine supplies, only in supermarkets and health food put together, not be allowed to enter pharmacy sales.

In recent years, however, FDA of China's acceptance of the way, has improved. According to its June 2004 launch of the new guidelines, pharmaceutical companies have been able to more easily into the development of herbal medicine to Western medicine. The end of last year, FDA approval of the new system comes into operation, for the first time approved a plant sale, which is named PolyphenonE the ointment for the treatment of venereal warts, it is made with green tea.

The guiding principles in a major policy change, that is, those who wish to use plant extracts to develop prescription drug companies, just an effective purification plant to extract, purify the material may contain hundreds Compounds, manufacturers no longer need to point out one by one each of the efficacy of compounds.

The implementation of the new policy to enable the FDA to submit a new drug application for listing of growth, FDA even established a special office to accept such applications, and herbal medicine have been employed by education experts to replenish the body. Born in China, graduated from the Beijing University of Chinese Medicine of the FDA Doujin Hui is the new "Botanical review group" of the drug review division.